BCL2L1 and breast carcinoma: In breast cancer, Bcl-xL is suggested to play a role in invasion and migration (Keitel et al., 2014), and in the highly invasive basal B subtype of triple-negative breast cancer, the combined overexpression of Bcl-xL and Aurora A has been found to promote metastasis (Skov et al., 2022).